Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP

• 主要な著者: Sarah M. Valencia (著者), Athina Zacharia (著者), Alexander Marin (著者), Rebecca L. Matthews (著者), Chia-Kuei Wu (著者), Breana Myers (著者), Chelsea Sanders (著者), Simone Difilippantonio (著者), Reinhard Kirnbauer (著者), Richard B. Roden (著者), Ligia A. Pinto (著者), Robert H. Shoemaker (著者), Alexander K. Andrianov (著者), Jason D. Marshall (著者)
• フォーマット: 図書
• 出版事項: Taylor & Francis Group, 2021-08-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Current human papillomavirus (HPV) vaccines provide substantial protection against the most common HPV types responsible for oral and anogenital cancers, but many circulating cancer-causing types remain for which vaccine coverage is lacking. In addition, all current HPV vaccines rely on aluminum sal...